0001209191-16-110843.txt : 20160328 0001209191-16-110843.hdr.sgml : 20160328 20160328214711 ACCESSION NUMBER: 0001209191-16-110843 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160322 FILED AS OF DATE: 20160328 DATE AS OF CHANGE: 20160328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330971591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 CAMBRIDGE AVE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-272-6138 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cory David A CENTRAL INDEX KEY: 0001670137 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 161533495 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-03-22 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001670137 Cory David A 350 CAMBRIDGE AVE, SUITE 350 PALO ALTO CA 94306 1 1 0 0 President and CEO Common Stock 56889 D Common Stock 30350 I See footnote 1 Stock Option (right to buy) 1.38 2023-09-24 Common Stock 17504 D Stock Option (right to buy) 2.06 2025-09-22 Common Stock 74393 D Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein. The option vests in equal monthly installments over 48 months measured from September 24, 2013 subject to Reporting Person's continuous service status as of each such date. The option will vest as to 25% of the option shares on September 22, 2016 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date. /s/ David Cory 2016-03-22